BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/15/2021 4:26:46 AM | Browse: 396 | Download: 917
 |
Received |
|
2020-12-08 08:59 |
|
Peer-Review Started |
|
2020-12-08 09:01 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-12-30 19:47 |
|
Revised |
|
2021-01-01 21:58 |
|
Second Decision |
|
2021-02-06 06:51 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-02-12 22:00 |
|
Articles in Press |
|
2021-02-12 22:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-03-10 06:24 |
|
Typeset the Manuscript |
|
2021-04-12 10:43 |
|
Publish the Manuscript Online |
|
2021-04-15 04:26 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Paradoxal relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maddalena Zippi, Sirio Fiorino, Roberta Budriesi, Matteo Micucci, Ivan Corazza, Roberta Pica, Dario de Biase, Claudio Giuseppe Gallo and Wandong Hong |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Maddalena Zippi, MD, PhD, Medical Assistant, Unit of Gastroenterology and Digestive Endoscopy, Sandro Pertini Hospital, Via dei Monti Tiburtini 385, Rome 00157, Italy. maddyzip@yahoo.it |
| Key Words |
COVID-19; Proton pump inhibitors; SARS-CoV-2, Severity; Mortality |
| Core Tip |
In the scenario of the current pandemic caused by the severe acute respiratory syndrome coronavirus 2 virus, it is essential finding the possible risk factors for the occurrence of its relative disease, including pharmacological therapies commonly taken by the population. Among these drugs, proton pump inhibitors (PPIs) represent one of the classes most widely used. In this review, we have tried to explore the link occurring between the use of proton pump inhibitors and the severe acute respiratory syndrome coronavirus 2 infection, analyzing the strengths and the weaknesses of this relationship, using the currently available data. |
| Publish Date |
2021-04-15 04:26 |
| Citation |
Zippi M, Fiorino S, Budriesi R, Micucci M, Corazza I, Pica R, de Biase D, Gallo CG, Hong WD. Paradoxal relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis. World J Clin Cases 2021; 9(12): 2763-2777 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i12/2763.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i12.2763 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
